166 related articles for article (PubMed ID: 32423377)
1. Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis.
You X; Zhou Y; Zhang J; Zhou Q; Shi Y; Su Z; Chen C; Shao R; Zhang J
BMC Nephrol; 2020 May; 21(1):183. PubMed ID: 32423377
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
3. Relationship between serum iPTH and peritonitis episodes in patients undergoing continuous ambulatory peritoneal dialysis.
Zhao Z; Yan Q; Li D; Li G; Cai J; Pan S; Duan J; Liu D; Liu Z
Front Endocrinol (Lausanne); 2023; 14():1081543. PubMed ID: 37051200
[TBL] [Abstract][Full Text] [Related]
4. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
Navarro JF; Mora C; Macia M; Garcia J
Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
[TBL] [Abstract][Full Text] [Related]
5. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
6. Conversion from Intravenous Vitamin D Analogs to Oral Calcitriol in Patients Receiving Maintenance Hemodialysis.
Thadhani RI; Rosen S; Ofsthun NJ; Usvyat LA; Dalrymple LS; Maddux FW; Hymes JL
Clin J Am Soc Nephrol; 2020 Mar; 15(3):384-391. PubMed ID: 32111702
[TBL] [Abstract][Full Text] [Related]
7. Secondary hyperparathyroidism and risk factors in patients undergoing peritoneal dialysis in a tertiary hospital.
Suwan N
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S101-5. PubMed ID: 22043575
[TBL] [Abstract][Full Text] [Related]
8. Oral paricalcitol versus oral calcitriol in continuous ambulatory peritoneal dialysis patients with secondary hyperparathyroidism.
Jamaluddin EJ; Gafor AH; Yean LC; Cader R; Mohd R; Kong NC; Shah SA
Clin Exp Nephrol; 2014 Jun; 18(3):507-14. PubMed ID: 23903802
[TBL] [Abstract][Full Text] [Related]
9. Suppression of parathyroid hormone secretion in CAPD patients by intraperitoneal administration of Maxacalcitol.
Murakami K; Miyachi H; Watanabe A; Kawamura N; Fujii M; Koide S; Murase M; Kushimoto H; Hasegawa M; Tomita M; Hiki Y; Sugiyama S
Clin Exp Nephrol; 2004 Jun; 8(2):134-8. PubMed ID: 15235930
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis.
Qi Q; Monier-Faugere MC; Geng Z; Malluche HH
Am J Kidney Dis; 1995 Oct; 26(4):622-31. PubMed ID: 7573017
[TBL] [Abstract][Full Text] [Related]
11. Predictors of patient survival in continuous ambulatory peritoneal dialysis: 10-year experience in 2 major centers in Tehran.
Hakemi MS; Golbabaei M; Nassiri A; Kayedi M; Hosseini M; Atabak S; Ganji MR; Amini M; Saddadi F; Najafi I
Iran J Kidney Dis; 2010 Jan; 4(1):44-9. PubMed ID: 20081304
[TBL] [Abstract][Full Text] [Related]
12. Calcium kinetic studies in patients on CAPD: improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover.
Kurz P; Tsobanelis T; Brunkhorst R; Roth P; Werner E; Schoeppe W; Vlachojannis J
Perit Dial Int; 1997; 17(1):59-65. PubMed ID: 9068024
[TBL] [Abstract][Full Text] [Related]
13. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal pulse calcitriol in the treatment of secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
Chan HW; Tsang WK; Chan CM; Fung SK; So SO; Tang HL; Tong MK; Lee KC; Chan AY
Perit Dial Int; 1998; 18(2):177-82. PubMed ID: 9576366
[TBL] [Abstract][Full Text] [Related]
15. Secondary hyperparathyroidism in diabetic and nondiabetic patients on long-term continuous ambulatory peritoneal dialysis (CAPD).
Nilsson P; Danielson BG; Grefberg N; Wide L
Scand J Urol Nephrol; 1985; 19(1):59-65. PubMed ID: 4023650
[TBL] [Abstract][Full Text] [Related]
16. Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial.
Ramirez-Sandoval JC; Arvizu-Hernandez M; Cruz C; Vazquez-Cantu B; Rojas-Concha LJ; Tamez L; Reynerio F; Gomez FE; Correa-Rotter R
J Nephrol; 2019 Aug; 32(4):645-659. PubMed ID: 30888584
[TBL] [Abstract][Full Text] [Related]
17. Incidence, etiology, and outcome of stroke in patients on continuous ambulatory peritoneal dialysis.
Toyoda K; Fujii K; Ando T; Kumai Y; Ibayashi S; Iida M
Cerebrovasc Dis; 2004; 17(2-3):98-105. PubMed ID: 14707407
[TBL] [Abstract][Full Text] [Related]
18. Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis.
Delmez JA; Slatopolsky E; Martin KJ; Gearing BN; Harter HR
Kidney Int; 1982 Jun; 21(6):862-7. PubMed ID: 6897087
[TBL] [Abstract][Full Text] [Related]
19. [Dynamic changes in calcium and phosphate plasma concentrations in the patients on peritoneal dialysis].
Jovanović N; Lausević M; Stojimirović B
Vojnosanit Pregl; 2006 Jan; 63(1):27-30. PubMed ID: 16471245
[TBL] [Abstract][Full Text] [Related]
20. Normal or low initial PTH levels are not a predictor of morbidity/mortality in patients undergoing chronic peritoneal dialysis.
Dimkovic NB; Bargman J; Vas S; Oreopoulos DG
Perit Dial Int; 2002; 22(2):204-10. PubMed ID: 11990405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
